Dark

VNDA
Vanda Pharmaceuticals Inc.
stock NASDAQ

At Close

Aug 14, 2026 3:59:51 PM EDT

5.22USD+3.777%(+0.19)964,643

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 14, 2026 9:25:30 AM EDT

5.07USD+0.795%(+0.04)460

After-hours

Aug 11, 2026 4:35:30 PM EDT

4.90USD-0.102%(-0.01)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 14, 2022

09:22AM EST Vanda Pharmaceuticals Inc. (VNDA) said that it has reached a License Agreement with MSN Pharmaceuticals Inc., MSN Laboratories Private Limited and Impax Laboratories to settle Vanda's patent litigation against MSN regarding MSN's Abbreviated New Drug Application seeking approval of its generic version of Vanda's HETLIOZ or tasimelteon. RTTNews

08:38AM EST Vanda Pharma Settles HETLIOZ Patent Litigation With MSN RTTNews

08:35AM EST Vanda Pharmaceuticals Settles HETLIOZ Patent Litigation With MSN Benzinga

Jan 4, 2022

08:20AM EST Vanda Pharmaceuticals Granted U.S. Patent Titled 'Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone' Benzinga

Dec 26, 2021

09:53AM EST The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year Benzinga

Nov 10, 2021

06:30PM EST Vanda Pharmaceuticals Announces Participation at November 2021 Investor PR Newswire

Nov 3, 2021

05:33PM EDT Vanda Pharmaceuticals: Q3 Earnings Insights Benzinga

05:22PM EDT Vanda Pharmaceuticals Cuts FY21 Sales Guidance From $270M-$300M To $260M-$290M Vs. $283.71M Est. Benzinga

05:20PM EDT Vanda Pharmaceuticals Q3 EPS $0.14 Misses $0.16 Estimate, Sales $70.09M Miss $75.00M Estimate Benzinga

04:02PM EDT Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results PR Newswire

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Nov 2, 2021

11:28AM EDT Vanda Pharmaceuticals Earnings Preview Benzinga

Oct 27, 2021

05:30PM EDT Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on PR Newswire

Oct 14, 2021

04:34PM EDT Vanda Pharmaceuticals Announces Participation At Evercore ISI's Catalyst Day Oct. 18 Benzinga

04:31PM EDT Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day PR Newswire

Sep 7, 2021

08:30PM EDT Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma PR Newswire

Aug 17, 2021

03:40PM EDT Vanda Pharmaceuticals Granted Patent 'Treatment of circadian rhythm disorders' Benzinga

Aug 16, 2021

01:26PM EDT Novavax Appoints New CFO Amid Inordinate Delay In COVID-19 Vaccine Authorization Benzinga

Aug 3, 2021

07:21AM EDT Vanda Closes Enrollment In ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients RTTNews

07:03AM EDT Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients Benzinga

07:01AM EDT Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing PR Newswire

Jul 28, 2021

04:24PM EDT Vanda Pharmaceuticals: Q2 Earnings Insights Benzinga

04:23PM EDT Vanda Pharmaceuticals Sees FY21 Revs $270M-$300M Vs $282.92M Benzinga

04:22PM EDT Vanda Pharmaceuticals Q2 EPS $0.17 Beats $0.14 Estimate, Sales $67.90M Miss $69.75M Estimate Benzinga

04:02PM EDT Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results PR Newswire

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 23, 2021

03:26PM EDT Bragar Eagel & Squire P.C. announcesthe proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative Litigation, Case No. 1:19-cv-04293-FB-LB in the United States District Court for the Eastern District of New York. GlobeNewswire Inc

Jul 21, 2021

04:31PM EDT Vanda Pharmaceuticals to Announce Second Quarter 2021 Financial Results on July PR Newswire

Jul 20, 2021

10:52AM EDT Vanda Pharmaceuticals Posts Clinical Trial Titled 'Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers' To ClinicalTrials.Gov Benzinga

Jul 1, 2021

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

May 12, 2021

04:31PM EDT Vanda Pharmaceuticals Announces Participation at Upcoming 2021 Investor PR Newswire

10:15AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021 Benzinga

06:25AM EDT B of A Securities Initiates Coverage On Vanda Pharmaceuticals with Buy Rating, Announces Price Target of $22 Benzinga

May 5, 2021

04:29PM EDT Vanda Pharmaceuticals Q1 EPS $0.15, Inline, Sales $62.70M Miss $68.50M Estimate; Sees FY21 Sales $270M-$300M vs $283.4M Est. Benzinga

04:02PM EDT Vanda Pharmaceuticals Reports First Quarter 2021 Financial Results PR Newswire

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 20, 2021

04:31PM EDT Vanda Pharmaceuticals to Announce First Quarter 2021 Financial Results on May PR Newswire

Apr 16, 2021

10:50PM EDT & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc. - VNDA PR Newswire

Mar 18, 2021

04:26PM EDT Shuman, Glenn & Stecker Investigates Vanda Pharmaceuticals Inc. Business Wire

09:11AM EDT Return On Capital Employed Overview: Vanda Pharmaceuticals Benzinga

Mar 12, 2021

10:50PM EST VANDA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc. - VNDA Business Wire

Feb 26, 2021

08:17AM EST The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida Benzinga

Feb 25, 2021

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

Feb 11, 2021

10:29AM EST Return On Capital Employed Overview: Vanda Pharmaceuticals Benzinga

Feb 10, 2021

04:28PM EST Recap: Vanda Pharmaceuticals Q4 Earnings Benzinga

04:03PM EST Vanda Pharmaceuticals Sees FY21 Sales Guidance Of $270M-$300M Vs $279.4M Estimates Benzinga

04:02PM EST Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial PR Newswire

04:02PM EST Vanda Pharmaceuticals Q4 EPS $0.15 Beats $0.14 Estimate, Sales $67.70M Beat $64.00M Estimate Benzinga

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

03:43AM EST Earnings Scheduled For February 10, 2021 Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Feb 2, 2021

04:30PM EST Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial PR Newswire

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 14, 2021

10:11AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2021 Benzinga

07:46AM EST Citigroup Downgrades Vanda Pharmaceuticals to Neutral, Announces $14 Price Target Benzinga

Dec 7, 2020

08:26AM EST Benzinga Pro's Top 5 Stocks To Watch For Monday, Dec. 7, 2020: ADBE, KODK, DRIV, GWRE, VNDA Benzinga

Dec 6, 2020

08:41AM EST Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace Benzinga

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

06:23PM EST FDA Approves HETLIOZ(r) (tasimelteon) for the Treatment of Nighttime Sleep PR Newswire

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Nov 29, 2020

08:59AM EST The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions Benzinga

Nov 28, 2020

01:08PM EST Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates Benzinga

Oct 29, 2020

09:32AM EDT Benzinga's Top Upgrades, Downgrades For October 29, 2020 Benzinga

09:00AM EDT Citigroup Upgrades Vanda Pharmaceuticals to Buy, Announces $14 Price Target Benzinga

Oct 28, 2020

04:04PM EDT Vanda Pharmaceuticals Sees FY20 Sales $240M-$260M Vs $251.05M Estimates Benzinga

04:03PM EDT Vanda Pharmaceuticals Q3 EPS $0.11 Beats $0.09 Estimate, Sales $60.30M Miss $63.95M Estimate Benzinga

04:01PM EDT Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire

Oct 27, 2020

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

Oct 26, 2020

04:02PM EDT Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New PR Newswire

04:01PM EDT Vanda Pharmaceuticals Receives FDA Approval To Proceed With Investigational New Drug VSJ-110 For Allergic Conjunctivitis Benzinga

Oct 21, 2020

04:45PM EDT Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on PR Newswire

Aug 31, 2020

06:30PM EDT Vanda Pharmaceuticals Provides Update on Tradipitant Development Program PR Newswire

Aug 18, 2020

07:59AM EDT Vanda Pharmaceuticals Inc. (VNDA) said the interim analysis of the ODYSSEY study showed that hospitalized patients with COVID-19 pneumonia improved sooner when treated with tradipitant as compared to placebo. RTTNews

07:28AM EDT Vanda Pharmaceuticals' Interim Analysis From ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement In Patients WIth COVID-19 Pneumonia Benzinga

07:14AM EDT Vanda Pharma: Interim Analysis Of ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement RTTNews

07:02AM EDT Vanda Pharmaceuticals Announces Interim Analysis From ODYSSEY Study Benzinga

07:01AM EDT Vanda Pharmaceuticals' Interim Analysis from ODYSSEY Study Shows Tradipitant PR Newswire

Aug 5, 2020

04:18PM EDT Vanda Pharmaceuticals Sees FY20 Sales $240M-$260M Vs $249.4M Estimates Benzinga

04:16PM EDT Vanda Pharmaceuticals Q2 EPS $0.16 Down From $0.21 YoY, Sales $62.20M Beat $61.95M Estimate Benzinga

04:02PM EDT Vanda Pharmaceuticals Reports Second Quarter 2020 Financial Results PR Newswire

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Aug 3, 2020

01:15PM EDT 5 Value Stocks In The Healthcare Sector Benzinga

07:15AM EDT Vanda Says FDA Accepted For Priority Review Applications For Smith-Magenis Syndrome RTTNews

07:02AM EDT FDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZ(r) PR Newswire

07:02AM EDT FDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZ in the Treatment of Smith-Magenis Syndrome Benzinga

Jul 29, 2020

05:00PM EDT Vanda Pharmaceuticals to Announce Second Quarter 2020 Financial Results on PR Newswire

Jul 13, 2020

04:36PM EDT FDA Grants Authorization For Individual Patient Expanded Access Protocol For The Use Of Tradipitant For Gastroparesis RTTNews

04:31PM EDT FDA grants authorization for Individual Patient Expanded Access Protocol for PR Newswire

04:30PM EDT Vanda Pharma Reports FDA Grants Authorization For Individual Patient Expanded Access Protocol For Use Of Tradipitant For Gastroparesis Benzinga